A study by the same laboratory showed that MEK1 is targeted by PADI2 in endometrial cancer and the citrullination event promotes MEK1-mediated phosphorylation of ERK1/2, facilitating tumour progression [83]. This evidence concerns the gene MAP2K1 and endometrial cancer.